Cempra to Participate in Jefferies 2015 Antibiotic Summit Investor Conference
16 mars 2015 17h21 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., March 16, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
25 févr. 2015 16h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Fourth Quarter and Full Year 2014 Financial Results
17 févr. 2015 08h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at Three Upcoming Investor Conferences
03 févr. 2015 08h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Announces Full Exercise of Additional Share Option and Completion of the Public Offering of Common Stock
13 janv. 2015 16h01 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Prices Public Offering of Common Stock
07 janv. 2015 20h00 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Announces Positive Topline Phase 3 Clinical Results for Oral Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
04 janv. 2015 17h00 HE
|
Melinta Therapeutics, Inc.
Solithromycin met the primary and secondary objectives of non-inferiority compared to moxifloxacin
Cempra to host webcast and conference call on January 5, 2015 at 8:00 a.m. EST
CHAPEL HILL,...
Cempra to Present at Two Upcoming Investor Conferences
10 nov. 2014 16h05 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update
29 oct. 2014 16h05 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on October 29, 2014
22 oct. 2014 07h30 HE
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...